# OnCo record nice-methods (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/nice-methods/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "nice-methods" ;
  schema:name "NICE technology appraisal methods (2022)"@en ;
  schema:alternateName "NICE methods"@en, "NICE methods review"@en, "NICE manual"@en, "PMG36"@en, "severity modifier"@en, "end-of-life criteria"@en, "cost per QALY threshold"@en, "NICE threshold"@en, "technology appraisal process"@en ;
  schema:description "The rulebook NICE uses to decide whether the NHS in England should pay for a medicine: a cost per quality-adjusted life year usually between 20,000 and 30,000 pounds, with extra weight since 2022 for severe diseases in place of the old bonus for end-of-life cancer drugs."@en ;
  schema:url <https://onco.cc/terms/nice-methods/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.nice.org.uk/process/pmg36> ;
  onco:tag "law", "uk" ;
  onco:related <https://onco.cc/terms/hta/>, <https://onco.cc/terms/cancer-drugs-fund/>, <https://onco.cc/terms/innovative-medicines-fund/>, <https://onco.cc/terms/icer-value-assessment/>, <https://onco.cc/terms/qol-pro/>, <https://onco.cc/terms/eu-hta-regulation/>, <https://onco.cc/terms/amnog/>, <https://onco.cc/terms/ilap/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/collections/nice-guidance/> ;
  onco:institutions <https://onco.cc/institutions/nice/>, <https://onco.cc/institutions/smc/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> .